Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Baijin Life Science HoldingsMNNGF 26 3-Year ROIIC % is 6.12 as of Mar. 2025, which is 57% below its 10-year median of 14.25. GuruFocus rates MNNGF with a GF Score™ of 26/100 and a GF Value™ of $0.05. The stock has 5 warning signs investors should review. Among 1,057 Retail - Cyclical companies, Baijin Life Science Holdings ranks better than 51.94% on this metric.
3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
Baijin Life Science Holdings's 3-Year ROIIC % for the quarter that ended in Mar. 2025 was 6.12%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
MNNGF's 3-Year ROIIC % is ranked better than 51.94% of 1057
companies
in the Retail - Cyclical industry
Industry Median: 4.82
vs MNNGF: 6.12
Baijin Life Science Holdings (OTCPK:MNNGF) 3-Year ROIIC % Explanation
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Baijin Life Science Holdings 3-Year ROIIC % Related Terms
Baijin Life Science Holdings 3-Year ROIIC % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Luxury Goods subindustry, Baijin Life Science Holdings's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Baijin Life Science Holdings 3-Year ROIIC % vs Retail - Cyclical Industry
For the Retail - Cyclical industry and Consumer Cyclical sector, Baijin Life Science Holdings's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Baijin Life Science Holdings's 3-Year ROIIC % falls into.
3-Year Incremental Net Operating Profit After Taxes (NOPAT)**
/
3-Year Incremental Invested Capital**
=
( 0.0546282 (Mar. 2025) - -1.323 (Mar. 2022) )
/
( 28.355 (Mar. 2025) - 5.736 (Mar. 2022) )
=
1.3776282
/
22.619
=
6.09%***
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Baijin Life Science Holdings (MNNGF) has a 3-Year ROIIC % of 6.12 as of Mar. 2025. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Baijin Life Science Holdings and its competitors. This is 57% below median its historical median of 14.25. According to the industry distribution chart, Baijin Life Science Holdings ranks #508 out of 1057 companies in the Retail - Cyclical industry, placing it in the top 48.1%.
Is Baijin Life Science Holdings' 3-Year ROIIC % too high?
Baijin Life Science Holdings' current 3-Year ROIIC % of 6.12 is 57% below median its 10-year median of 14.25. The Retail - Cyclical industry median 3-Year ROIIC % is 4.82. Baijin Life Science Holdings' value of 6.12 is 27% above this industry median. Based on the distribution chart, Baijin Life Science Holdings ranks #508 out of 1057 companies in the Retail - Cyclical industry, which is above the industry midpoint. Overall, Baijin Life Science Holdings has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does Baijin Life Science Holdings' 3-Year ROIIC % compare to TPR?
According to the Retail - Cyclical industry distribution chart, Baijin Life Science Holdings ranks #508 out of 1057 companies for 3-Year ROIIC %. This puts Baijin Life Science Holdings in the upper half of its industry. The industry median 3-Year ROIIC % is 4.82. Baijin Life Science Holdings' value of 6.12 is 27% above this benchmark. While the company's 10-year median is 14.25 vs. the industry median of 4.82, Baijin Life Science Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Retail - Cyclical company?
The median 3-Year ROIIC % among Retail - Cyclical companies is 4.82, based on 1,057 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Baijin Life Science Holdings's current 3-Year ROIIC % of 6.12 is 27% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Baijin Life Science Holdings and its competitors. For the Retail - Cyclical industry, the median 3-Year ROIIC % is 4.82 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Baijin Life Science Holdings's current 3-Year ROIIC % is 6.12, which is 57% below median its own 10-year median of 14.25. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Baijin Life Science Holdings stock overvalued right now?
Baijin Life Science Holdings (MNNGF) has a current 3-Year ROIIC % of 6.12. The stock's GF Value™ is $0.05, compared to a current price of $0.08 — trading 50% above its estimated fair value. The current 3-Year ROIIC % is 6.12, which is 57% below median its 10-year median of 14.25 and 27% above the Retail - Cyclical industry median of 4.82. Baijin Life Science Holdings' overall GF Score™ is 26/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For Baijin Life Science Holdings (MNNGF), the current 3-Year ROIIC % is 6.12 as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Baijin Life Science Holdings (MNNGF) Overvalued in 2026?
Based on GuruFocus' analysis, Baijin Life Science Holdings stock appears to be overvalued.
The current stock price of $0.08 is trading 50% above its estimated GF Value™ of $0.05.
Key valuation signals for MNNGF:
3-Year ROIIC %: 6.12 (57% below median its 10-year median of 14.25)
GF Value™: $0.05 vs. price of $0.08 (50% above fair value)
Industry Position: 27% above the Retail - Cyclical median (#508 of 1057)
No single metric tells the full story. See the MNNGF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Baijin Life Science Holdings Ltd is positioned as a biopharmaceutical company dedicated in anti-aging and preventive medicine, as well as cellular precision therapy. The company has three business segment: jewelry business segment; strategic investment segment; and skincare business segment. The majority of revenue is coming from jewelry business segment.
26GF Score
Get the complete analysis for MNNGF
3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MNNGF has been successfully added to your 
